Abstract: The invention relates to a process for the manufacture of a fat mixture, where said process comprises the steps where in the first step 60-95 wt % of quark, and 5-40 wt % of milk base are mixed to obtain a quark blend, in the second step 9-62 wt % of at least one edible plant oil, is added to 38-91 wt % of the quark blend, followed by mixing to obtain the fat mixture. The invention also relates to a fat mixture obtainable by said process and to uses of said fat mixture in food products.

Abstract: The invention relates to a whey protein product having a ratio of whey protein to casein in the range from about 90:10 to about 50:50 and the total protein content of at least 20% on dry matter basis, and a method for its preparation. The product has a favourable amino acid composition and is especially suitable for athletes.

Abstract: Methods and compositions for promoting tolerogenic immune responses or treating immune responses to food antigens comprise Lactobacillus GG. Oral administration of Lactobacillus GG to patients such as human infants may promote a tolerogenic immune response to antigens in cow's milk.

Abstract: The invention relates to a method for increasing the concentration of the cis-9, trans-11 isomer of octadecadienoic acid in the milk fat and/or the tissue fat of a ruminant. In the method the ruminant is fed the trans-11 isomer of octadecenoic acid either as such or mixed with other feed, separately or together with other fatty acids.

Abstract: Methods and compositions for promoting tolerogenic immune responses or treating immune responses to food antigens comprise Lactobacillus GG. Oral administration of Lactobacillus GG to patients such as human infants may promote a tolerogenic immune response to antigens in cow's milk.

Abstract: The present invention provides method of making a protein hydrolysate formula and protein hydrolysate formulas made thereby for downregulating hypersensitivity and for promoting gut immune barrier, and methods of preventing or treating allergies, especially cow's milk allergy by combining the protein with probiotic gastrointestinal bacteria, especially Lactobacilli. The probiotics make it possible to influence the immunological balance, whereby allergy can be prevented by affecting the initiation mechanism of allergy. The present invention makes it possible to develop a person's tolerance of proteins by actively promoting a tolerogenic immune response. In addition, present invention provides for administering fragments of an allergen modified by probiotic gastrointestinal bacteria in order to desensitize a immune response to systemic hyporesponsiveness.

Abstract: The invention relates to inhibition of clostridia with lactic acid bacteria. In particular, the invention relates to the use of Lactobacillus rhamnosus in the food industry to inhibit the growth and activity of clostridia. Preferred embodiments of the invention include the use of Lactobacillus rhamnosus in prevention of butyric acid fermentation and in cheese production.

Abstract: The invention relates to new Streptococcus thermophilus strains containing genes giving the bioluminescence property. The strains can be applied widely for analytical purposes, e.g. in the determination of bacteriophages and antibiotics, especially from liquid samples. The invention also relates to a test set containing a bioluminescent Streptococcus thermophilus strain, and to processes for the determination of bacteriophages or antibiotics from a liquid sample.

Abstract: A method for removing phenylalanine from proteinaceous compositions is disclosed wherein the protein contained in the proteinaceous composition is degraded enzymatically with a proteolytic enzyme into a protein hydrolysate. The protein hydrolysate thus obtained is treated with adsorption resin in a column that is eluted with water, the fraction wherefrom phenylalanine has been removed is recovered and salts are removed from the fraction thus recovered. Finally the recovered fraction is concentrated and dried. A palatable proteinaceous composition from which phenylalanine has been removed is also disclosed. This proteinaceous composition is used as a special nutrient preparation or a component of such in the diet of patients suffering from phenylketonuria.